Home > Healthcare > Pharmaceuticals > Finished Drug Form > Anti-snoring Treatment Market

Anti-snoring Treatment Market Share

  • Report ID: GMI3998
  • Published Date: Apr 2023
  • Report Format: PDF
 Download Free Sample

Anti-snoring Treatment Market Share

Some of the key companies in the global anti-snoring treatment industry include:

  • Apnea Science
  • SomnoMed
  • Koninklijke Philips
  • Airway Management Inc
  • Tomed GmBH
  • Meditas
  • GlaxoSmithKline Plc
  • Fisher & Paykel Healthcare
  • ResMed
  • Theravent (Foundation Consumer Healthcare)
  • The Pure Sleep Co (Sleep Science Partners, Inc)
  • Vyaire Medical.
Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for anti-snoring treatment was worth USD 1 billion in 2022 and is projected to expand at an 8% CAGR from 2023-2032.

Continuous positive airway pressure (CPAP) devices is expected to record more than 7.5% between 2023 and 2032, driven by the rising prevalence of OSA.

North America anti-snoring treatment market is poised to surpass USD 1 billion by 2032, owing to supportive government initiatives and awareness campaigns.

Apnea Science, SomnoMed, Koninklijke Philips, Tomed GmBH, Meditas, ResMed, and Vyaire Medical are some of the leading companies in the market.

Anti-snoring Treatment Market Scope

  • Anti-snoring Treatment Market Size
  • Anti-snoring Treatment Market Analysis
  • Anti-snoring Treatment Market Share

    • Buy Now

    Premium Report Details

    • Base Year: 2022
    • Companies covered: 12
    • Tables & Figures: 384
    • Countries covered: 27
    • Pages: 163
     Download Free Sample
    Download PDF Copy
    ×
    Get a free sample of Anti-snoring Treatment Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.